et al. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J 2006; 20:2153–5. , ,
Agonists of Toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am J Respir Crit Care Med 2005; 171:814–22. , , , , , .
A phosphatidylserine species inhibits a range of TLR, but not IL-1β, induced inflammatory responses by disruption of membrane microdomains. J Immunol 2008; 181:5606–17. , , , , , , , .
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13:851–6. , , , , , .
The inflammatory response to cell death. Annu Rev Pathol 2008; 3:99–126. , .
Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis. Am Heart J 2005; 150:488–99. , , , , , , , .
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685–95. .
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611–8. , , , , , .
Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999; 34:1975–81. , , , , , , .
The role of immune activation in endotoxin-induced atherogenesis. J Endotoxin Res 2001; 7:322–6. , , , , , .
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185–92. , , , , , , , .
et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004; 101:10679–84. , ,
Translational mini-review series on Toll-like receptors: networks regulated by toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 2007; 147:199–207. , , .
Toll-like receptors in health and disease: complex questions remain. J Immunol 2003; 171:1630–5. , , , , , .
Regulation of Toll-Like receptors in human monocytes and dendritic cells. J Immunol 2001; 166:249–55. , , , , , .
et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000; 275:11058–63. , ,
Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001; 89:244–50. , , , , .
et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005; 94:831–8. , ,
Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105:1158–61. , , , .
Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. Am J Pathol 2006; 168:1396–403. , , , , , , .
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model. Cardiovasc Res 2005; 68:493–501. , , , , , , .
Toll-Like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168:4701–10. , , , , .
Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci USA 2007; 104:17034–9. , , , , .
P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br J Pharmacol 2007; 151:115–27. , , , , , , , .
Contribution of toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109:1574–83. , , , .
TLR4 antagonists for endotoxemia and beyond. Curr Opin Investig Drugs 2005; 6:496–502. , .
Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76:514–9. , .
Tissue factor expression in endothelial cell/monocyte cocultures stimulated by lipopolysaccharide and/or aggregated IgG. Mechanisms of cell : cell communication. J Immunol 1991; 146:1437–45. , , , , , .
A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 1993; 178:2193–200. , , .
Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor release and augment neutrophil elastase release. J Biol Chem 1997; 272:11778–85. , , .
et al. Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 2007; 190:443–51. , ,
et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 2008; 117:2670–83. , ,
Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 2003; 111:1011–20. , , , , , , .
Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006; 12:133–50. , , , .
Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001; 15:825–35. , , , , , .
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821–52. , , , .
TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120:247–54. , , .
Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19:281–6. , .
et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127:89–97. , ,
et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003; 100:1966–71. , ,